Correvio Pharma Corp.

(CORV) Trade

By |

Profile

Correvio Pharma Corp, formerly Cardiome Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are AGGRASTAT, EXEMBOL, BRINAVESS and others. The firm earns revenue from the sale of company's commercialized products. It has Europe and Rest of the world geographic segments.

Contact Information

Website: www.correvio.com
Email: ir@correvio.com
Main Phone: +1 604 677-6905
Address: 1441 Creekside Drive
Address 2: 6th Floor
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6J 4S7

Issuer Information

Exchange: NSC
CEO: William L. Hunter
Employees: 138
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Correvio Pharma Corp, formerly Cardiome Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are AGGRASTAT, EXEMBOL, BRINAVESS and others. The firm earns revenue from the sale of company's commercialized products. It has Europe and Rest of the world geographic segments.

Contact Information

Website: www.correvio.com
Email: ir@correvio.com
Main Phone: +1 604 677-6905
Address: 1441 Creekside Drive
Address 2: 6th Floor
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6J 4S7

Issuer Information

Exchange: NSC
CEO: William L. Hunter
Employees: 138
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.95 $ -0.05 (-2.50%)
Last Price 1.95 Change $ -0.05 Change % -2.50 Tick N/A
Bid 1.94 Bid Size 500.00 Ask 2.06 Ask Size 400.00
Open 1.98 High 2.07 Low 1.93 Prev Close 2.00
Last Trade Volume 50,239 52 Wk Hi 5.24 52 Wk Low 1.92
Market Cap 77.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,019,001.00 EPS (TTM) -0.40 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9.5 9.5 9.5 9.5
Low Target Price Estimate 3.3 3.3 3.3 3.3
Mean Target Price Estimate 5.45 5.45 5.45 5.45
Standard Deviation 2.79 2.79 2.79 2.79
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 06/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.33 1.33